Morozov A I, Rogachikova T A, Korshunov A I, Biriukov V A, Roshchina V S
Med Radiol (Mosk). 1985 Feb;30(2):31-5.
The paper is concerned with the results of open field gamma-beam therapy and gamma-therapy using gamma-beam forming agents. Besides, a method of simultaneous chemo- and radiotherapy was used for 175 nasopharyngeal cancer patients. Of them 2 had Stage II tumors, 22 Stage III tumors, 151 (first admitted for treatment as well as those with recurrences and tumor metastases), by local spread and regional and distant metastatic spread, had Stage IV tumors. A single focal dose was 1.4-2.5 Gy, the summary dose 55-70 Gy. In simultaneous chemo- and radiotherapy using gamma-beam forming agents the values of a single and the summary focal dose did not lessen; a single and the summary dose of chemotherapeutic drugs got less and equaled 1/2-2/3 of standard dosages. The chemotherapeutic component of multimodality chemotherapy was indicated with regard to a tumor histological structure. The best results were achieved in the group of patients on multimodality chemo- and radiotherapy. Of 75 patients, a complete or partial tumor resorption was noted in 71. With the use of all the methods of radio- and multimodality therapy the 3-year survival was 41.1%, the 5-year survival 19.4% (34 patients out of the 175).
本文关注的是开放野伽马射线束治疗以及使用伽马射线束形成剂进行伽马治疗的结果。此外,对175例鼻咽癌患者采用了同步放化疗方法。其中2例为Ⅱ期肿瘤患者,22例为Ⅲ期肿瘤患者,151例(包括初次接受治疗以及复发和肿瘤转移患者)因局部扩散、区域和远处转移扩散而处于Ⅳ期肿瘤。单次局部剂量为1.4 - 2.5 Gy,总剂量为55 - 70 Gy。在使用伽马射线束形成剂进行同步放化疗时,单次和总局部剂量的值并未降低;化疗药物的单次和总剂量降低,相当于标准剂量的1/2 - 2/3。多模式化疗的化疗成分根据肿瘤组织学结构而定。在多模式放化疗患者组中取得了最佳结果。75例患者中,71例出现了肿瘤完全或部分消退。使用所有放疗和多模式治疗方法后,3年生存率为41.1%,5年生存率为19.4%(175例中有34例)。